Stock MVR0 MEDIVIR AB
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Medivir AB Deutsche Boerse AG

Equities

MVR0

SE0020181014

Delayed Deutsche Boerse AG
Other stock markets
 08:57:50 17/07/2024 BST 		5-day change 1st Jan Change
0.22 EUR -3.51% Intraday chart for Medivir AB -11.65% +0.55%
06-27 Medivir AB Presents Positive New Data from Its Ongoing Phase Ib / IIa Study of Fostroxacitabine Bralpamide + Lenvima® in Advanced Hepatocellular Carcinoma CI
06-20 Certain Shares of Medivir AB are subject to a Lock-Up Agreement Ending on 20-JUN-2024. CI

Evolution of the average Target Price on Medivir AB

Price target over the last 5 years

History of analyst recommendation changes

13d.AvnHRO163u99USl7Uv7DZMJ_emWjCAiwWeu0SNEgVKw.UoqBCL8TqKlOIUEXOZyuMbU8LhHUSTHqM4DtC4ZxAOVpj7UBlwKTmxxnTg~b2e9a13b75483e9174cd1d5c9ed0b309

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
2.87 SEK
Average target price
20.91 SEK
Spread / Average Target
+628.44%
High Price Target
54 SEK
Spread / Highest target
+1,781.53%
Low Price Target
9 SEK
Spread / Lowest Target
+213.59%

Consensus detail

Consensus revision (last 18 months)

Ratings for Medivir AB

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MVIR B Stock
  4. MVR0 Stock
  5. Consensus Medivir AB